Locally advanced cervical cancer
Conditions
Interventions
The 3D-printed, patient-tailored ARCHITECT applicator
Sponsors
Erasmus MC, Universitair Medisch Centrum Rotterdam
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: 18 years or older;Locally advanced cervical cancer (FIGO stage 1B3-IVA) with indication for primary radiotherapy including brachytherapy;Written informed consent
Exclusion criteria
Exclusion criteria: Unable to give informed consent;Tumour extension in the lower 2/3rd of the vagina;Requiring a Geneva tandem with ovoids’ size 13 mm in BT1;Known nylon allergy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The clinical feasibility of the use of the patient-tailored ARCHITECT applicator in locally advanced cervical cancer brachytherapy will be assessed. This is defined as the ability to treat the patient during the second application using the 3D printed patient-tailored applicator. | — |
Secondary
| Measure | Time frame |
|---|---|
| Brachytherapy-related adverse events, brachytherapy implant geometry and plan quality, user experience, time required for the workflow, pain perceived by the patient during the day of the IGABT, and integrity of the patient-tailored applicator will be evaluated. | — |
Countries
Netherlands
Contacts
Public ContactH. Westerveld
Erasmus MC, Universitair Medisch Centrum Rotterdam
Outcome results
None listed